Meet Jeuveau® (prabotulinumtoxinA-xvfs) injection our newest treatment. Pronounced “joo-voh”, it is the first FDA-approved product of its kind that is committed solely to aesthetics. Approved by the FDA on February 1, 2019, Jeuveau® (prabotulinumtoxinA) is stirring excitement throughout the aesthetic world.
Thanks to Jeuveau®, there’s help for moderate to severe glabellar lines. What’s a glabellar line? Those pesky little wrinkles between your eyebrows that won’t go away—aka frown lines. Jeuveau® is a modern-made neurotoxin produced using a state-of-the-art manufacturing process.
Jeuveau® is an injectable treatment given by a specialist to relax the muscle contractions that form frown lines. The result? In clinical trials, Jeuveau® was shown to temporarily improve the appearance of moderate to severe frown lines between the eyebrows in adults. In 2 long-term safety studies, patients received an average of 3 treatments over the course of 1 year.
• Jeuveau® is a modern-made neurotoxin and the first and only neurotoxin
approved exclusively for aesthetics. There is a lot of excitement about Jeuveau® as it’s the first neurotoxin to hit the U.S. market in almost a decade. Furthermore, Jeuveau® has also been studied in the largest head-to-head aesthetic clinical trial versus Botox® Cosmetic.
• Aesthetics Only: Jeuveau® is the first neurotoxin to come to market in almost a decade and the only one dedicated exclusively to aesthetics.
• Modern-Made: Jeuveau® is a modern-made neurotoxin, produced in a state-of-the-art facility using Hi-Pure® technology.
• Clinically Proven: Jeuveau® is backed by studies of more than 2,100 patients including two Phase III U.S. trials, the largest head-to-head aesthetic trial versus Botox® Cosmetic, as well as two long-term safety studies.
$9/unit when you purchase 20+ units